Tefferi, A., Pardanani, A. and Gangat, N. (2023) “Momelotinib (JAK1/JAK2/ACVR1 inhibitor): mechanism of action, clinical trial reports, and therapeutic prospects beyond myelofibrosis”, Haematologica. Pavia, Italy, 108(11), pp. 2919-2932. doi: 10.3324/haematol.2022.282612.